A Study Comparing of P-GEMD Regimen Versus P-Gemox Regimen With Untreated Early-Stage NUAT or Advanced-Stage ENKTL.

NCT06953739 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

NK-T-Cell Lymphoma, Extranodal

Interventions

DRUG: P-GEMD
DRUG: P-Gemox

Sponsor

The First Affiliated Hospital with Nanjing Medical University